Seeing some signs that may indicate a silent disease

May is dedicated to brain cancer awareness, a silent disease that occurs in any type of malignant tumor in the brain. The Gray May campaign seeks to provide information about the different types of brain cancer that can occur in different parts of the brain and the need to be aware of the signs.

According to data from the National Cancer Institute (INCA), this disease accounts for about 4% of cancer cases in Brazil, is most common in people over 50 years of age and ranks tenth on the list of tumors that cause the most deaths in Brazil. . Brazil.

To understand the symptoms and treatment of the disease, Earth you Talk to your neurosurgeon, member of the Brazilian Society of Neurosurgery, Felipe MendezThis explains the differences that this type of cancer can cause.

symptoms

According to the specialist, the signs may vary depending on the area of ​​the tumor, its size, and its growth rate, and it is necessary to seek medical help when noticing some of these signs:

• Persistent headache that gradually worsens.
• seizures;
• nausea;
• Vomiting.
• Communication difficulties;
• Visual changes.
• loss of balance;
• Behavioral changes.

As for risk factors, the doctor points out that some diseases and genetic syndromes, such as neurofibromatosis, increase the chance of developing brain tumors. In addition, exposure to ionizing radiation is also a known risk factor.

Who is Isabel Veloso? A 17-year-old influencer suffering from terminal cancer

treatment

The neurosurgeon confirms that the treatment of brain cancer is individual and depends on the type of tumor, its origin, location and stage, in addition to the clinical condition of each individual and the presence of pre-existing health problems.

Options include surgery, radiation therapy, and chemotherapy. The goal of surgery is to safely remove as much of the tumor as possible.

“In many cases, surgery alone may be sufficient. However, in other cases, a combination of methods such as radiotherapy or chemotherapy may be necessary.

Recent studies include new immunotherapies that enhance the patient’s immunity to the tumor. The use of more targeted molecular and gene therapies, based on tumor characteristics, is also highlighted, as well as the anticipation of the use of artificial intelligence to improve diagnosis and clinical planning that could expand the horizons of oncology care.

Source: Redação Terra Você